Navigation Links
Amarantus BioSciences to Present at the 2012 National Investment Banking Association Conference in New Orleans
Date:2/23/2012

SUNNYVALE, Calif., Feb. 23, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class disease–modifying therapeutic protein, today announced that Gerald E. Commissiong, President and CEO, will present the Company's updated business plan at the 2012 National Investment Banking Association (NIBA) conference on Thursday, February 23, 2012 at 12:25pm CST at Le Pavillon Hotel in New Orleans, LA. Mr. Commissiong will also be holding 1-on-1 meetings with investors.

About Amarantus BioSciences, Inc.

Amarantus BioSciences, Inc. is a development-stage biotechnology company founded in January 2008.  The Company has a focus on developing certain biologics and biomarkers surrounding the intellectual property and proprietary technologies it owns and has rights to for the treatment and diagnosis of Parkinson's disease and other human diseases.  The Company owns the intellectual property rights to an anti-apoptotic therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF"), and owns an inventory of 88 cell lines referred to as "PhenoGuard Cell Lines" from which MANF was discovered. The Company also has a license to the NuroPro™ diagnostic test for Parkinson's disease from Power3 Medical Products. For further information please visit www.amarantus.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about the possible benefits of MANF therapeutic applications, advantages presented by Amarantus' PhenoGuard technology, and/or possible benefits of the NuroPro™ diagnostic platform, as well as statements about expectations, plans and prospects of the development of Amarantus' new product candidates. These f
'/>"/>

SOURCE Amarantus BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amarantus BioSciences and Generex Biotechnology Collaborate on Cell Therapy for Late Stage Diabetes
2. Amarillo Biosciences Appoints Dr. Stephen Chen as Chairman and CEO
3. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
4. GeneLink Biosciences Completes Sale of GeneWize Life Sciences
5. Ambit Biosciences to Present at Two Upcoming Investor Conferences
6. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
7. Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast
8. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
9. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
10. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
11. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... ... Since its inception in 2004 PhUSE has become the ... for European Statistical Programmers, has evolved in the past eleven years to a ... Managers and Biostatisticians all over the world, share, contribute and advance at various ...
(Date:7/7/2015)... ... July 07, 2015 , ... The Pistoia Alliance, a ... in life science R&D, has attracted a number of new members from across ... pharmaceutical company joining as a Core member, and DNAnexus and Tessella as Participating ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... Personalized Medicine, recently hosted their 2015 bi-annual Pain Management Medical Advisory Board meeting ... with Proove Biosciences’ executive Research and Development team to discuss new clinical practice ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... molecular diagnostic tests are key drivers of the global molecular diagnostics market. BCC ... and the introduction of new companion diagnostic tests will increase demand for inexpensive ...
Breaking Biology Technology:PhUSE Delighted to Welcome Member Number 5.000 2Pistoia Alliance Continues to Attract New Members 2Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 2Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 3Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 2Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 3
... computing that you should improve processes before you automate them. ... could just get its act together and tell us clearly ... only objective is to automate what youre already doing, it ... of technology value on the table and presumes the luxury ...
... Lucigen Corporation has been awarded the maximum ... under a special SBIR grant program for its enzyme ... new products and technologies with high potential value. , ... funds raised by Lucigen from outside investors. , ,The ...
... that it will repurchase up to 5% of its ... the open market or in private transactions in a ... ,"Third Wave's stock repurchase program underscores the confidence of ... and long-term outlook," said John Puisis, president and CEO ...
Cached Biology Technology:Innovate, Automate, or Improve? You Don't Have to Choose. 2Innovate, Automate, or Improve? You Don't Have to Choose. 3
(Date:7/7/2015)... July 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... growing mobile commerce market announces a revised version of one of ... commercial will air on CNBC in New York ... and San Francisco metro areas.    ... on Wocket,s ability to replace all the cards in your wallet ...
(Date:7/2/2015)... Sweden , July 2, 2015 ... sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor World ... one of FPC,s distributors in Asia . ... 2015. The sensors will be used by smartphone manufacturers in ... MSEK is included in the communicated revenue guidance of approximately ...
(Date:6/29/2015)... Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ... America Biomedical Sensors Market - Growth, Trends & Forecasts ... Latin America Biomedical Sensors market is estimated at $0.65 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
Breaking Biology News(10 mins):Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Latin America Biomedical Sensors Market Report 2015-2020 2
... competing for awards that recognize their research, according to ... Science Foundation and sponsored by the Association for Women ... teaching awards in proportion to the number of women ... Anne Lincoln at Southern Methodist University in Dallas. That,s ...
... by scientists from the Virginia Bioinformatics Institute (VBI) at ... distinct genetic changes differentiating cancer patients from healthy individuals ... The multidisciplinary team, which includes researchers from ... a design for a new DNA microarray that allows ...
... Starting in 2011, Chinese Science Bulletin , ... will be published as open access journals and added to ... Chinese Library of Science (CLoS), a collection comprising more than ... www.springerlink.com . Chinese Science Bulletin and ...
Cached Biology News:Gender gap: Selection bias snubs scholarly achievements of female scientists 2New technology pinpoints genetic differences between cancer and non-cancer patients 2Selected journals in Springer's Chinese Library of Science join SpringerOpen 2
Salmonella typhimurium Immunogen: Heat inactivated bacterial cells of Salmonella typhimurium B Storage: 4 C...
... High Performance, 5 ml. The same ... HiTrap Streptavidin columns for fast, reliable ... into Tricorn 5/50 GL, XK 16/20, ... purifications are required.Extremely useful for exploiting ...
... Immunogen: Synthetic peptide derived ... human SENP1. Specificity: Specific ... SENP1. Reactivity: Human (positive ... Hep2 cell lysates HL-60 cell ...
...
Biology Products: